Almost three-quarters of all marijuana purchased in California this year will be of the illicit variety.
History may repeat itself come December.
Despite providing a financial foundation for retirees over eight decades, the program has two egregious flaws that are hitting many seniors right in their pocketbooks.
It's probably less than you think.
More than 450 cases of mysterious lung illnesses, along with five deaths, have been reported across 33 states.
Despite production and margin improvements, there are some serious red flags in Aurora's Q4 report.
These big-time cannabis growers offer incredible value to would-be suitors.
While no longer considered the equivalent of a sell, this cannabis stock is far from a buy.
When the wind blows, do the economy and stock market bend?
Hint: It has nothing to do with earnings reports.
This cannabis grower is worthy of a buy rating, but that's not what it received.
Yes, you can generate recurring income from cannabis stocks.
Aurora is set to report its fiscal fourth-quarter results on Wednesday, but its headline figures shouldn't be the focus.
Plunging global yields have created the perfect scenario for precious metals to thrive.
North American cannabis sales are set to surpass $47 billion in less than five years, according to Prohibition Partners.
Some well-known companies have propped up Berkshire Hathaway's portfolio this year.
These under-the-radar pot stocks could run circles around their larger peers.
Three vertically integrated multistate operators look attractive to Canaccord Genuity.
Cannabis stocks have had little issue raising capital. But they're also spending their money at a rapid pace.
These countries are expected to account for virtually all of the legal marijuana sold globally in five years.